新型冠状病毒

FDA approves new Covid-19 boosters from Pfizer and Moderna

Drug regulator’s decision is the first step towards a new round of jabs as cases rise in the US

The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US.

Anyone 5 years of age and older will be eligible to receive an updated jab from either Moderna or BioNTech/Pfizer as long as it has been at least two months since a previous Covid-19 vaccination, the Food and Drug Administration said on Monday.

“The FDA anticipates that the updated vaccines will be available in the near future,” the regulator said, without giving a specific date. A Centers for Disease Control and Prevention advisory panel is set to meet on Tuesday to discuss its recommendations for who should receive the jab, and after its decision distribution could begin as soon as this week.

您已阅读29%(763字),剩余71%(1862字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×